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Abstract
Clays have previously demonstrated potential as drug delivery carriers for the 
extended release of a variety of drugs. The objective of this study was to develop and 
characterise drug-containing clays in combination with natural hydrogels for the 
preparation of lyophilised xerogels. Sulfathiazole (STH) (a hydrophobic model drug) was 
intercalated within the interlayer spaces of Laponite® RDS (LAP RDS) or refined 
montmorillonite (MMT) and then mixed with either carageenen 812 (CAR 812) or 
hydrohydroxy ethyl cellulose (HEC) hydrogels prior to lyophilisation. The resulting 
xerogels were characterised visually, using differential scanning calorimetry (DSC) and 
with scanning electron microscopy (SEM). Optimal geo-polymeric wafers contained 
1.5% W/W CAR 812 with 2% LAP RDSand 1% W/W intercalated STH. DSC and SEM 
results indicated the amorphous form of STH was intercalated inLAP RDS within theleafy 
structure of CAR 812. This xerogel hydrated up to1700% within 40 minutes and released 
the STH by Higuchikinetic model. 
Keywords: Polymer; Clay, Intercalation, Xerogel, Wound delivery, Amorphous, 
Physicochemical characterisation, Polymers, hydrogel, drug delivery, lyophilised wafer.
Abbreviations
STH (Sulfathiazole), LAP (Laponite), MMT (montmorillonite), CAR (carrageenan), 
HEC (hydrohydroxy ethyl cellulose), DSC (differential scanning calorimetry), SEM 
(scanning electron microscopy), polyethylene glycol (PEG). 
Introduction
Drug-delivery systems composed of natural materials have become increasingly 
important because of their nontoxicity and biodegradability [1]. Amongst the diverse 
range of natural materials investigated for this purpose, clays have demonstrated useful 
properties for pharmaceutical, clinical and general health applications attracting 
increasing interest over the last decade; although the therapeutic effects of clays have 
been referred to from prehistoric times [2, 3].
Montmorillonite (MMT) and refined MMT are natural clay minerals with a high 
internal surface area, high cation exchange capacity, high adsorption ability, and low 
toxicity [4]. Due to the negatively charged layers, the swelling of these clays in the 
presence of water is high and positively charged species can be intercalated into the 
interlayer spaces via electrostatic interactions. Laponite® (LAP), a synthetic layered 
silicate with the chemical formula NaC0.7 [(Si8Mg5.5Li0.3) O20 (OH) 4] ‾K0.7 is composed of 
disc-shaped nanoparticles of 25 nm diameter and 1 nm layer thickness [5]. Some 
octahedral magnesium ions in the octahedral sheets are replaced with lithium ions so 
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negatively charged layers are present which are compensated 
for with exchangeable sodium ions in the interlayer space. The 
film forming ability of these materials is a desirable property 
for the development of mucosal films for novel drug delivery 
systems [6]. Tixogel VZ and VP are synthetic organophilic clays 
with high thixotropic properties and can be used as anti-settling 
agents in low polarity systems. They can be dispersed in 
alcohols or ketones following a high agitation process [7].
The use of clay minerals for human health is not restricted 
to pharmaceutical excipients and cosmetics [8] as recently 
clays have demonstrated potential as carriers for the delivery 
and extended release of a variety of drugs [9]. Studies on the 
mobility of chemical elements from healing clays to the human 
body during topical applications and ingestion were under 
taken by [6, 10, 11]. Many formulations are based on the 
intercalation of molecules between the interlayer spaces of the 
clay enabling the incorporation of either hydrophilic or 
hydrophobic drugs via the exchange of small two dimensional 
organic molecules, inorganic and organic ions or polymeric 
ions with the ions originally present within the clay structure 
[12, 13]. For example Beak, et al. [14] intercalated glutathione 
in montmorillonite for antioxidant delivery with the aim of 
protecting the drug molecules from chemical and enzymatic 
hydrolysis following oral ingestion. Ibuprofen, the most 
common medicine for rheumatoid arthritis, osteoarthritis and 
moderate pain treatment, was intercalated in montmorillonite 
to minimize side effects [15]. The intercalated formulation 
controls the drug release and minimizes frequent side effects 
within the gastrointestinal tract and the ulcerogenic effect [16].
Clay:polymer nanocomposites are widely used in the 
materials industry where the addition of clay can be used to 
enhance the physical and engineering properties of a material 
[17] and there is increasing interest in the use of clay-polymer 
composites for pharmaceutical applications such as tissue 
engineering and drug delivery [9, 18]. Although individually, 
both biopolymers and clays are present in many drug delivery 
systems a hybrid of the two can provide enhanced properties 
to a drug delivery matrix such as improved water uptake, 
increased mechanical strength, improved rheology and 
modified drug release. 
Carrageenan and hydroxyethyl cellulose (HEC) are both 
natural products commonly used for the formulation of drugs. 
More recently they have been used to prepare buccal [19] and 
lyophilised xerogels [20] for drug delivery and wound healing 
[20, 21]. Lyophilised xerogels are shaped hydrophilic polymer 
glasses that adhere to the wound, adsorb fluid and form a 
viscous gel releasing any drugs contained within. 
In this present study a model drug, Sulfathiazole (STH, 
figure 1), was intercalated into various clays(LAP, MMT, refined 
MMT, Tixogel VZ and Tixogel VP) and thenincorporated into 
a natural hydrogel consisting of either carrageenan or 
hydroxyethyl cellulose. The gels were subsequently lyophilised 
to form a dry xerogel. The composition of the xerogel was 
varied in terms of type and quantity of clay, polymer and drug 
to produce a matrix with optimal properties for wound healing 
and drug delivery applications. STH (pKa=7.2), an antimicrobial 
drug, is a weak acid with extremely low solubility in water 
(LogP=0.35). Formulation methodology was developed and 
optimal conditions (hydration time, pH, and clay concentration) 
for an even distribution of the drugs and clays within the 
aqueous polymeric matrix were realised by intercalating STH 
into the interlayers of refined MMT and various grades of LAP. 
Figure 1. Chemical structure of Sulfathiazole (STH).
Experimental and methods
Materials
MMT, refined MMT, various Tixogels (VP & VZ; CAS: 
67479-91-8) and all LAP grades (CAS: 227605-22-3, XL21, 
RDS, RD and WXFP) were kindly gifted from BYK(Widnes, UK). 
Sulfathiazole (STH; CAS: 72-14-0, batch number: 053K3451) 
and Chitosan medium molecular weight (CAS: 9012-76-4, 
batch number: MKBH1108V) were purchased from Sigma 
Aldrich. The PEG 1500 (CAS: 25322-68-3, batch number: 
ZA3726628) was purchased from BDH and Hydroxethylcellulose 
(CAS: 9004-62-0, batch number: P-0189) from Aqualon 
Hercules. Carrageenan 812(CAS: 9000-07-1 232, Gelcarine) 
was kindly gifted from FMC BioPolymer company.
Dispersion of clays
A gradual ratio of MMT, refine MMT, Tixogels or various 
LAP grades [0.5-20%(w/w)] were added to 50 mL deionized 
water in separate beakers (200 mL) and stirred vigorously at 
800rpm for 30 minutes at room temperature. The visual 
properties were inspected and initial pH determined before 
the drop wise addition of 1M NaOH or HCl while recording 
the pH accordingly. In order to enhance the solubility and 
obtain an even dispersion of 0.5-1.5% (w/w) MMT and Tixogels 
within the system, a gradual volume of ethanol (2-20 mL) was 
added while the mixture was constantly agitated. Furthermore, 
0.5-1.5% (w/w) MMT or Tixogels were dispersed in 20 mL 
ethanol or propanol and the physical properties evaluated. 
Intercalation of STHinto MMT and LAP
A 2% dispersion of clay (LAPs and MMT) was produced by 
adding the clay to deionized water while agitating vigorously 
(800rpm) at room temperature for 30 minutes. Then STH (0.2-
1g) was slowly added to this dispersion with the gradual 
addition of 3 mL NaOH to ionize the drug with on-going 
agitation for a further 45 minutes. To reduce the time required 
for the intercalation process a second technique was employed 
where the drug was ionized prior to addition to the clay 
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dispersion; STH (0.2-1g) was dissolved in 3 mL of NaOH and 
the ionized drug solution added to 47ml of the 2% (w/w) 
refined MMT or LAP dispersion and stirred (800rpm) at room 
temperature for 10 min. This process was repeated at 40°C.
Gel preparation
Polymers [1-4% PEG 1500, 1-4% Hydroxyethyl cellulose, 
0.5-1.5% Ƙ-carrageenan 812 (CAR), and 0.5-2% Carbopol 940] 
were added to 50ml deionized water with stirring (500rpm) at 
40°C for 20 minutes. The dispersion of 1-2.5% chitosan 
required acidic conditions so 0.5-2% medium molecular 
weight chitosan was added to deionized water and HCl (1M) 
added dropwise to pH 1-2 to obtain a transparent gel.
Polymer-clay hydrogel preparation
Two different techniques were compared for the preparation 
of drug containing polymer-clay hydrogels.
1. Polymer dispersions were prepared (according to 
section 2.4) and solid clay added (2% w/w) with 
stirring at 800 rpm and 40°Cuntil the clay was 
completely dispersed in the polymeric matrix. Then 
the ionized drug (0.2-1g in 3ml NaOH) was introduced 
to the system with stirring for 10 minutes. 
2. A polymer dispersion was produced using half the 
required total volume of deionised water (gel 
preparation section) and a clay dispersion with 
intercalated drugs prepared using the other half (as 
described in intercalation section). Then the polymer 
dispersion was added to the clay dispersion with 
stirring hence maintaining the same final 
concentrations of components.
3. Finally, a gradual concentration of STH (0.2-1g) was 
dissolved in 2 mL ethanol and added to the 2% LAPs 
and refine MMT dispersions with on-going stirring.
Formulation of drug delivery system
Following the even distribution of clay and drug within 
the polymeric matrices, potential forms of drug delivery 
systems were evaluated. The hydrogels were divided into 
three equal portions and treated as follows:
a) Left as a hydrogel.
b) Oven dried in apetri dish at 40°C for 24 hours.
c) Lyophilised in a six-well tissue culture plate for 24 
hours at -50°C (Mini-LyotrapFD/85002 freeze dryer). 
Differential Scanning Calorimetry (DSC)
Samples were analysed using a PE DSC8000 (Perkin Elmer, 
Bucks., UK) and Pyris software to investigate the stability of 
the materials during the gel formation and lyophilisation 
processes. The DSC was calibrated using standard reference 
materials of indium (melting temperature 156.6°C, Δ Hf 28.45 
J g-1) and zinc (melting temperature 419.47°C). 
Samples of 3 - 10 mg were accurately weighed into 
standard aluminium sample pans, crimped and placed into 
the DSC with a blank crimped standard pan as reference. The 
samples were analysed using a cool-heat cycle with a scan 
rate of 10°C min-1 throughout and a 20 ml min-1 nitrogen 
purge. The method was as follows for MMT, HEC, CAR 812 
and LAP RDS: i) initial temperature 25°C, hold for 1 minute, ii) 
cool to -50°C, hold for 1 minute iii) heat to 350°C, hold 1 
minute, iv) re-cool to -50°C, hold for 1 minute v) final re-heat 
to 350°C, hold for 1 minute. The method was modified using 
a maximum temperature of 205°C for analysis of STH and 
200°C, for the optimal xerogels. Tm and Tg values were 
calculated using extrapolated onset values from endotherms 
or exotherms and extrapolated half cp values, respectively.
Scanning electron microscopy
Scanning electron microscopy (SEM) was used to evaluate 
the topographic characteristics and morphology of the 
xerogels. The analyses were carried out using a JeolJSM-
6490LV Instrument (Tokyo, Japan) with back-scattered 
electrons and artificial shadowing ability for uncoated samples 
at low vacuum (520 Pa) and an accelerating voltage of 20 kV.
Hydration and swelling studies 
This study was conducted to investigate the maximum 
time required for complete hydration as well as the maximum 
swelling capacity of the xerogel using phosphate buffer 
solution (pH=7.5) to mimic wound fluid. Samples were cut to 
2 cm×2 cm pieces, weighed and placed in 50 mL of the buffer 
media. The weight change in the sample was measured by 
removing the sample, blotting, then weighing every 10 
minutes until a constant weight was maintained. The% 
swelling (% weight change) for the polymeric matrices was 
calculated using equation 1 where W0 and Wt are the weights 
of the xerogel initially and at time t respectively. Each data 
point represents the mean (± s.d), of three replicates. 
% Swelling=(W0- Wt)/W0 ×100 Eqn 1
Drug release studies 
STH release studies were performed at 37°C using 
phosphate buffer (pH = 7.2) in a dissolution bath. Approximately 
0.2-0.3g of lyophilised xerogels were placed in 50 mL phosphate 
buffer to simulate the wound surface fluid secretion and 
dispersed for 4 hours. Dissolution media samples were taken at 
2 min intervals from time zero. The amount of STH released 
(mg) was calculated by UV spectrometry (λ=283 nm) and 
cumulative percentage release versus time profiles plotted. The 
kinetics of STH release from the geo-polymeric xerogel was 
assessed by fitting the dissolution data (percentage cumulative 
release against time) to the Higuchi, Hixon–Crowell, Korsmeyer–
Peppas, first or zero order equations in order to determine the 
drug release mechanism. As a model-dependent approach, the 
dissolution data was fitted to five common release models i.e. 
zero order, first-order, Higuchi, Hixon-Crowel and Korsmeyer-
peppas equations. The kinetic model with the highest coefficient 
correlation (r) was assumed to the most appropriate model for 
the dissolution data. 
Results and discussion
Visual evaluations 
Preliminary visual observations were performed on the 
initial clay dispersions, polymericgel, dried films and lyophilised 
xerogels to evaluate them in terms of; ease of pouring, stability, 
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flexibility and the even distribution of the components within 
the matrix with no air bubbles in the films. The fragility and 
brittleness of a matriximpacts on the physical and mechanical 
stability during handling and storage. For wound healing 
applications, a xerogel must also be soft and flexible to provide 
the desirable mechanical strength during handling and comfort 
upon the application without potential irritation [22]. In addition, 
an ideal xerogel should have an optimum thickness of less than 
1mm as thicker preparations maybe difficult to apply without 
disturbing the wound surface. Thickness also affects both the 
rate of hydration and the diffusion distance of the drug through 
the resulting swollen gel which can have significant effects on 
drug release profiles [20, 21].
The maximum concentration of the different clays which 
could be dispersed evenly in deionized water is shown in table 1 
and the highest ratio achieved was 20% LAP RDS. However at 
these concentrations, the viscosity of the hydrogels increased 
dramatically resulting in thick gels containing air bubbles that 
were not easy to pour. The optimum concentration of refined 
MMT and LAPs that could be dispersed in water with the 
desirable viscosity was determined to be 2% (figure 2). 
Interestingly, during the dispersion process applying heat 
reduced the dispersion time and produced LAPs hydrogels with 
a more desirable transparency and flow-ability. Therefore, for the 
next stage the various grades of LAPs and refined MMT were 
assessed for drug intercalation and incorporation into hydrogels.
Figure 2. 2% pure (e) Laponite and (f) refine MMT dispersion.
The Tixogels (VZ and VP) which are organic in nature and 
MMT did not disperse in aqueous media (table 1) but dispersed 
in pure organic solvents such as ethanol or isopropyl alcohol. 
However, for pharmaceutical applications this is not acceptable 
as a consequence of potential toxicity or irritations. Furthermore, 
the addition of a small quantity of deionised water resulted in the 
precipitation of the clays producing two separated phases. 
All the clays assessed were basic in nature and the initial 
pH of the aqueous dispersions was approximately pH=9. STH 
is also a weak acid so ionization required basic conditions to 
feasibly accommodate it between the interlayer spaces of 
clays via ion exchange. The addition of STH shifted the pH to 
around 11. This basic pH of the clay-drug combination had a 
direct impact on the miscibility within the polymeric matrixes. 
It was also observed that increasing the pH of the clay 
dispersion increased the viscosity, whereas in acidic condition 
the reverse occurred (table 1) and this impacted on the 
stability of the hydrogel during storage and the lyophilisation 
process. 
A range of polymers were selected for the preliminary 
hydrogel formulation studies (table 2). Carbopol 940 and low 
MW chitosan required acid conditions to fully disperse in 
water which disintegrate the clay-drug dispersion. Table 2 
demonstrates that HEC, Carrageenan and PEG 1500 all 
produced transparent hydrogels within a pH range of 6-7 so 
it was concluded that basic or neutral polymers would be the 
most compatible clay-containing matrices for future studies. 
The viscosity of the hydrogel is also very important and very 
low viscosity polymeric hydrogels are not desirable as they 
can show phase separation during storage at room 
temperature. For example, the gel comprising of 10% PEG 
1500, 2% LAP and 1% STH separated due to the low viscosity 
of PEG 1500 which enabled the clay and drug to drift to the 
bottom of the container. This also occurred when the 
concentration of HEC was 1%, producing a gel with low 
viscosity which also phase separated. The viscosity of the 
polymeric matrix needs to be high enough to entrap the clay 
and drug providing an even distribution of all the components 
during storage. 
From the preliminary studies, the hydrogel systems with 
the most desirable properties consisted of either 3% HEC, 2% 
LAP or MMT or 1.5% CAR and 2% LAP or MMT in combination 
with 1% drug. These were remade and split into 3 portions; a 
hydrogel, a dryfilm and a lyophilised xerogel. In both cases, 
the hydrogel system remained stable after 1 month storage at 
room temperature with an even distribution of the components 
(Figure 3a and b). The dried film was extremely brittle and 
hence did not meet the criteria which is a soft and robust 
texture to be mechanically stable and convenience for wound 
healing applications. So it was not considered further as a 
potential drug delivery system (Figure 3c and d). 
Table 1. Physico-chemical characteristics of clays’ dispersions in deionized water also basic and acidic condition (pH=1-2& pH=13-14).
Maximum clay (% w/w) Initial  pH Initial characteristics Acidic pH characteristics Basic pH characteristics
5 % Laponite RD 9.21 Transparent, viscose gel,   Transparent, viscose gel,   Transparent, viscose gel,   
0.5% Tixogel VZ NA Suspension, quickly separated Sit on the aqueous phase Sit on the aqueous phase
4% Refined MMT 9.32 Stable suspension, not transparent Stable suspension, opaque Stable suspension, opaque
0.5% MMT NA Suspension, quickly separated Sit on the aqueous phase Sit on the aqueous phase
20% Laponite RDS 9.2 Transparent solution,    Transparent solution,    Transparent solution,    
4% Laponite WXFP 9.59 Viscose gel, transparent Viscose gel, transparent Viscose gel, transparent
4% Laponite XL21 9.39 Transparent solution, Transparent solution, Transparent solution, 
0.5% Tixogel VP NA Suspension, quickly separated Sit on the aqueous phase Sit on the aqueous phase
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Table 3. Visual characteristics of clays’ dispersions in the polymers’ matrices
2% (w/w) clay Polymers (%w/w) Characteristics
Laponite RD 2% HEC Transparent, low viscosity gel 
Refined MMT 2% HEC Yellow cloudy gel, low viscosity 
Laponite RDS 2% HEC Transparent, low viscosity gel 
Laponite WXFP 2% HEC Transparent, low viscosity gel 
Laponite XL21 2% HEC Transparent, low viscosity gel 
Laponite RD 3% HEC Transparent, good viscosity 
Refined MMT 3% HEC Yellow cloudy gel, good viscosity 
Laponite RDS 3% HEC Transparent, good viscosity 
Laponite WXFP 3% HEC Transparent, good viscosity 
Laponite XL21 3% HEC Transparent, good viscosity 
Laponite RD 1.5% CAR Transparent, good viscosity 
Refined MMT 1.5% CAR Yellow cloudy gel, good viscosity 
Laponite RDS 1.5% CAR Transparent, good viscosity 
Laponite WXFP 1.5% CAR Transparent, good viscosity 
Laponite XL21 1.5% CAR Transparent, good viscosity 
Laponite RD 2% CAR Transparent, high viscosity, trapped air bubbles 
Refined MMT 2% CAR Yellow cloudy gel, high viscosity, trapped air bubbles 
Laponite RDS 2% CAR Transparent, high viscosity, trapped air bubbles
Laponite WXFP 2% CAR Transparent, high viscosity, trapped air bubbles 
Laponite XL21 2% CAR Transparent, high viscosity, trapped air bubbles 
Figure 3. Demonstrate the images of hydrogels contain (a) 3% w/w 
HEC + 2% w/w Laps + 1%w/wSTH, (b) 3% w/w HEC + 2% w/w refine 
MMT + 1% w/w STH and dried film of (c) 3% w/w HEC + 2% w/w Laps 
+ 1% w/w STH (d) 3% w/w HEC + 2% w/w MMT + 1% w/w STH
However, the lyophilised xerogels, in particular the HEC 
based ones, showed good physical properties in terms of 
softness and flexibility (Figure 4 a, b and c). A wound delivery 
system should be soft and flexible enough to prevent 
discomfort and potential damage to the wound surface while 
possessing sufficient stability to remain durable during the 
application. The CAR based xerogels were dried completely 
after 24 hours freeze-drying but the rigidity was high and 
would require the addition of a plasticizer to be appropriate 
as a desirable wound delivery system (Figure 4d and e).
Differential scanning calorimetry (DSC)
DSC traces for the raw materials showed that no melting 
endotherms were detected for CAR 812, LAP RDS, refined MMT 
or HEC, although broad endotherms between 50º C-150º C 
indicated moisture loss. The large exothermic event at 214º C 
observed for CAR 812 confirmed the onset of degradation. 
During the first heating cycle three sharp endothermic peaks 
with extrapolated onset temperatures at 166.51º C, 173.66º C 
and 201.08º C were observed from STH (form III (Tm), transition 
of form III and form I(Tm)), respectively. However, after quench 
cooling these crystalline forms became amorphous due to the 
instability of polymorphs and a glass transition temperature 
(Tg, at half cp) was detected at 63.29 º C (figure 5a). 
The optimal xerogels were also analysed by DSC (figure 5b- 
5e). The DSC thermograms from 3% HEC, 2% LAP RDS and 1% 
STH- 3% HEC, 2% MMT, 1%STH- 1.5% CAR, 2% LP RDS, 1%STH 
as well as 1.5% CAR, 2% MMT, 1%STH showed only moisture loss 
indicating that the STH was in the amorphous form in all of them. 
The absence of STH melting peaks in DSC thermograms 
of xerogels showed that during the formulation process 
including intercalation, heating, stirring, mixing with hydrogels 
or lyophilisation, all the STH polymorphs were converted to 
the amorphous form of the drug. 
In figure 5b & 5c, the glass transition point may be masked 
by the broad endotherm peak due to moisture loss from the 
MMT and HEC.
Additionally, the thermograms in figures 5d & 5e are 
demonstrating the broad endotherm peak due to moisture 
loss from the LAP and MMT and a sharp peakendothermic 
superimposed with onset around 87 °C, followed by an 
exothermic eventat around 160°C indicating that the matrix 
stability has decreased and the geo-polymeric xerogel 
degraded, probably due to the presence of the CAR 812. 
Table 2. Characteristics of polymers in aqueous media
Maximum (%w/w) Polymers pH pH stability Characteristics
2% Carbopol 940 4-5 3.5-10 Yellowish transparent, good viscosity gel 
3% Hydroxyethyl Cellulose 6-8.5 3-10 Clear and transparent gel, high viscosity
1.5% Ƙ-Carregeenan 812 5-6 4.3-12 Yellowish transparent gel, good viscosity gel 
10% PEG 1500 5-7 4-9 Transparent, very low viscosity gel
2% Chitosan Medium MW 4-6 2.3-6.3 Yellowish transparent, good viscosity gel at pH=2
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Figure 4. Representative digital images ofxerogel prepared from 
hydrogels comprising (a) 3% w/w HEC + 2% w/w Laps + 1% w/w 
STH, (b) 3% w/w HEC + 2% w/w refine MMT + 1% w/w STH, (c) 3% 
w/w HEC + 2% w/w refine MMT+1% w/w STH, (d) 1.5% w/w CAR + 
2% w/w refine MMT + 1% w/w STH, (e) 1.5 w/w CAR+ 2% w/w LAP 
RDS+ 1% w/w STH
Figure 6. Demonstrating SEM images of xerogel prepared from 
hydrogels comprising (a) 3% w/w HEC+ 2% w/w refined MMT+1% 
w/w STH, (b)3% w/w HEC+2% w/w refine MMT+1% w/w STH, (c) 
1.5% w/w CAR+2% w/w LAP RDS+1% w/w STH, (d) 1.5% w/w 
CAR+2% w/w LAP RDS+1% w/w STH
Figure 5. Representative DSC thermograms of xerogel prepared 
from hydrogels comprising (a)Sulfathiazole (STH), (b)3% w/w HEC + 
2% w/w LAP RDS + 1% w/w STH, (c) 3% w/w HEC + 2% w/w refine 
MMT + 1% w/w STH, (d) 1.5% w/w CAR + 2% w/w LAP RDS + 1% 
w/w STH, (e) 1.5% w/w CAR + 2% w/w refine MMT + 1% w/w STH
The results illustrate the effect of either formulation 
process or the amorphous nature of CAR or LAP RDS on 
transformation of crystalline STH to amorphous form which 
needs to be investigated. This can accelerate the release of 
STH from the matrix due to its higher solubility over crystalline 
form [23, 24]. 
Scanning electron microscopy (SEM)
SEM was employed to assess the surface morphology of 
the lyophilised geo-polymeric xerogels and observe the effect 
of the microstructure on the swelling properties. According to 
the SEM data (Figure 6a-d), the presence of CAR 812 resulted 
in a more compact, leafy structure with smaller pores 
compared to the larger pores in observed in the HEC materials. 
These pores potentially provide extra spaces for occupation 
by the active compounds, increasing drug loading and also 
enabling faster water ingress consequently affecting the 
release of the drug after administration [19].
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Hydration and swelling studies 
It was observed that when the geo-polymeric xerogels 
comprising HEC were immersed in buffer (pH=7.2) they 
swelled vigorously within 10 min (figure 7). The complete 
demolition of the xerogel structure and resultant dispersion 
offine pieces within the media made the measurement of 
weight gain impossible. The complete hydration of CAR 812 
based xerogel occurred over 40 minutes and the discs 
remained intact due to themorphology and more impenetrable 
structure. The overall weight gain after 40 min reached 1700% 
and 1550% of initial weight for CAR based xerogels comprising 
LAP RDS and MMT respectively.
Figure 7. Swelling graph of xerogel comprising 3% w/w HEC+ 2% 
w/w refined MMT + 1% w/w STH, and 1.5% w/w CAR+ 2% w/w LAP 
RDS + 1% w/w STH
Following the placement of a polymeric xerogel matrix in 
a moist environment (such as the wound mucosa), the swelling 
process begins by the ingress of water or body fluids. In the 
early stages, water penetrates into the xerogel due to a 
concentration gradient which results in mobility enhancement 
of the polymer chains and hydration of the clays. This 
phenomenon increases the macromolecular mobility at a 
specific clay-polymer-water concentration. Subsequently the 
clay’s hydration and polymer chains relaxation (hydration) 
increase the water content and mesh size of the clay: polymer 
network within the formulation. The relaxation step for CAR 
812 based systems will be accelerated as the polymer’s Tg of 
CAR is below the temperature of the swelling media. 
In addition, the effect of CAR 812 on hydration profiles 
was more dominant compared to HEC which is attributed to 
differences observed in the micro-structure observed in the 
SEM images. According to the SEM results (Figure 6a-6d) the 
presence of CAR 812 resulted in xerogels with smaller pores 
and therefore, less capacity for water ingress and consequently 
they were hydrated to a lesser extent.
Drug release 
The release profile of STH from 2% MMT, 3% HEC, 1% STH 
also 2%MMT, 1.5% CAR, 1%STH and 2% LAP RDS, 1.5% CAR, 
1% STH as well as 2% LAPS, 3% HEC, 1% STH samples are 
demonstrated in Figure 8. The mechanism of STH release 
from hydrophilic polymeric matrices (CAR or HEC) involves 
solvent penetration, hydration and swelling of the CAR or 
HEC, diffusion of the dissolved STH from the geo-polymeric 
matrices, and erosion of the hydrogel layer. Primarily, the 
diffusion coefficient of drug in the dehydrated CAR or HEC 
matrix is low butit rises considerably as time progresses and 
the CAR and HEC imbibe more water and form gels.
Figure 8. Dissolution graph of xerogel comprising (a) 3% w/w HEC+ 
2% w/w refine MMT + 1% w/w STH, (b) 1.5% w/w CAR+ 2% w/w LAP 
RDS + 1% w/w STH (c) 3% w/w HEC + 2% w/w LAP RDS + 1% w/w 
STH and d)1.5% w/w CAR + 2% w/w refine MMT + 1% w/w STH.
Various parameters such as hydrogel composition (type 
of polymer, type of drug and excipients), geometry (size and 
shape), preparation technique and the drug release conditions 
affect the kinetics of drug release [25]. These phenomena 
stimulate the wetting of the drug delivery system to facilitate 
the ingress of the medium. The degradation of the polymer 
promotes diffusion of drug through the polymer matrix, 
hence CAR with more cross-links and higher density absorbs 
less water and subsequently releases the STH considerably 
slower than the HEC matrix.
The coefficient (r2) value for 5 different kinetic models is 
shown in table 4. A comparison of the r2 values confirm that 
STH is released from the 3% HEC, 2%MMT and 1.5% CAR 812, 
2% LAP matrices according to the Hixson-Crowellkinetic 
model (eqn 2) whereas the Higuchi kinetic model (eqn 3) 
determines the release of STH from 1.5% CAR 812, 2% MMT 
and 3%HEC, 2% LAP RDS samples. 
Table 4. r2 value for the variousKinetic model of STH release from 
geo-polymeric matrixes 
Release kinetic S1 S2 S3 S4
Zero order 0.692 0.943 0.924 0.809
First order 0.771 0.915 0.873 0.595
Higuchi 0.870 0.982 0.824 0.933
Hixson– Crowell 0.975 0.971 0.976 0.634
Peppas 0.634 0.869 0.734 0.835
S1:2% MMT, 3% HEC, 1% STH; S2:2%MMT, 1.5% CAR, 1%STH; S3: 2% 
LAP RDS, 1.5% CAR, 1% STH
S4: 2% LAPS, 3% HEC, 1% STH
3 Q0 +3 Qt = MHC
t Equation2: Hixson-Crowell 
Mt
A =  D(2c0-cs)cst) 
   Equation3: Higuchi
It is assumed in Hixson-Crowell release kinetics that the 
release rate is limited by the dissolution rate of the drug particles 
and not by diffusion through the polymeric matrix; this model 
describe the release profile considering the diminishing surface 
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of the drug particles during the dissolution [26]. The Hixson-
Crowell cube root law describes the release of the STH from 
xerogels where the surface area and diameter of delivery system 
is critical. The dissolution rate of STH from the surface of geo-
polymeric systems is proportionally to diminishing polymers 
(CAR or HEC), in such a manner that the initial geometrical form 
remains constant [27].
The Higuchi kinetic model however describes the STH release 
as a diffusion process based in the Fick’s law, square root time 
dependent [28]. Fickian diffusion refers to the STH transport process 
where the polymer relaxation time (tr) is much greater than the 
characteristic solvent diffusion time (td).This equation has been 
used successfully to describes the experimentally observed in vitro 
release STH from polymers (HEC and LAP RDS or CAR 812 and 
MMT) where erosion or swelling of the polymeric matrix does not 
contribute to drug release during the short time period [29, 30]. 
Overall, in both kinetic models, the release of STH from CAR 
and HEC involves water diffusion and chain disentanglement at 
the final stage. Though the polymer dissolution does not result 
in the scission of polymer chains, it results in the loss of bulk 
material. CAR 812 and HEC experience dissolution in the 
aqueous medium due to water penetration effect, swelling, and 
polymer chain disentanglement and relaxation. The fractional 
release of STH from xerogels consisting of HEC and CAR 812 
matrices corresponded well with the fractional release of HEC 
and CAR812, indicating drug release is primarily driven by 
dissolution and followed by erosion [31].
Conclusion 
These results demonstrate that due to strong cross-linked 
polymer chains CAR 812 sustains the release of STH from the 
geo-polymeric matrices for up to 2 h due to the prolonged 
hydration of the matrix. This favours the delivery of STH to 
wound surfaces from CAR 812 matrices over the extremely 
fast hydration and drug release from the HEC based geo-
polymeric matrices which would also be displaced from the 
wound surfaces due to the generation of a slippery residue 
following the fast polymer degradation. 
Overall, a comparison of the four optimized xerogels 
demonstrated that the matrix comprising 1.5% CAR 812, 2% LAP 
RDS and 1% STH possessed the most desirable stability, swelling 
and drug release for wound deliver applications. The DSC results 
confirmed that any STH present was in an amorphous form, 
which supports data from dissolution studies that confirmed the 
effect of the drug dissolution rate on release kinetic. The presence 
of the STH in amorphous form increased the dissolution rate 
which can be advantageous where the purpose of the application 
is obtaining the fast release of antibiotic from the wound delivery 
system. However it might be not desirable if the drug release 
should be prolonged and over a longer period of time. Ideally, 
the most efficient system in order to deliver the antibiotic to the 
wound surfaces should be capable to release the drug rapidly 
after the application followed by a gradual release over the time 
[32]. This will be obtained by designing the most optimised 
combination of hydrogel polymer and clay to develop a stabilized 
geo-polymeric matrix. 
Acknowledgment 
We would like to announce special gratitude to BYK 
additive Ltd Company for sponsoring this project. 
References
1. Rodrigues LA, Figueiras A, Veiga F, et al. The systems containing clays 
and clay minerals from modified drug release: a review. Colloids Surf B. 
2013; 103: 642-51. doi: 10.1016/j.colsurfb.2012.10.068
2. Carretero MI, Gomes CSF, Tateo F. Clays and human health. In: Bergaya 
F, Theng BKG, Lagaly G, edtors. Handbook of Clay Science. Developments 
in Clay Science. Amsterdam Elsevier. 2006; 1: 717-741.
3. Gomes CSF, Pereira Silva JB. Minerals and clay minerals in medical 
geology. Appl Clay Sci. 2007; 36: 4-21. doi: 10.1016/j.clay.2006.08.006
4. Nuruzzaman MD, Rahman MM, Liu Y, Naidu R. Nanoencapsulation, 
Nano-guard for Pesticides: A New Window for Safe Application. J Agric 
Food Chem. 2016; 64 (7): 1447-1483. doi: 10.1021/acs.jafc.5b05214
5. Kroon M, Vos WL, Wegdam GH. Structure and formation of a gel of colloidal 
disks. Phys Rev E. 1998; 57: 1962–1970. doi: 10.1103/PhysRevE.57.1962
6. Park TU, Jung H, Kim HM, Choy JH, Lee CW. Hybrid of itraconazole, 
cyclosporine of carvedilol with a layered silicate and a process for 
preparing the same. 2004; WO Patent 2004/009120. 
7. http://www.byk.com/en/additives/additives-by-name/cloisite.php.
8. López-Galindo A, Viseras C, Cerezo P. Compositional, technical and 
safety specifications of clays to be used as pharmaceutical and cosmetic 
products. Appl Clay Sci. 2007; 36: 51-63. doi: 10.1016/j.clay.2006.06.016
9. Viseras C, Aguzzi C, Cerezo P, Lopez-Galindo A. Uses of clay minerals in 
semisolid health care and therapeutic products. Appl Clay Sci. 2007; 36 
(1–3): 37-50. doi: 10.1016/j.clay.2006.07.006
10. Tateo F, Summa V. Element mobility in clays for healing use. Appl Clay 
Sci. 2007; 36: 64-76. doi: 10.1016/j.clay.2006.05.011
11. Jung H, Kimc HM, Choy YB, Hwang SJ, Choy JH. Laponite-based nanohybrid 
for enhanced solubility and controlled release of itraconazole. Int J Pharm. 
2008; 349: 283-290. doi: 10.1016/j.ijpharm.2007.08.008
12. Liu B, Luo J, Wang X, Lu J, Deng H and Sun R. Alginate/quaternized 
carboxymethyl chitosan/clay nanocomposite microspheres: preparation 
and drug-controlled release behavior.J. Biomater. Sci Polym Ed. 2013; 
24(5): 589-605. doi: 10.1080/09205063.2012.701160
13. Paek SM, Jung H, Lee YJ, Park M, Hwang SJ, Choy JH. Exfoliation and 
reassembling route to mesoporous titania nanohybrids. Chem Mater. 
2006; 18: 1134-1140. doi: 10.1021/cm052201d
14. Baek M, Choyb JH, Choia SJ. Montmorillonite intercalated with glutathione 
for antioxidant delivery: Synthesis, characterization, and bioavailability 
evaluation. Int J Pharm. 2012; 425: 29-34. doi: 10.1016/j.ijpharm.2012.01.015
15. Zheng JP, Luan L, Wang HY, Xi LF, Yao KD. Study on ibuprofen/
montmorillonite intercalation composites as drug release system. Appl 
Clay Sci. 2007; 36: 297-301. doi: 10.1016/j.clay.2007.01.012
16. Abdeen R and Salahuddin N. Modified Chitosan-Clay Nanocomposite as 
a Drug Delivery System Intercalation and In Vitro Release of Ibuprofen. 
JChemistry. 2013. doi.org/10.1155/2013/576370.
17. Gao F. Clay/polymer composites: the story. Mar today. 2004; 7 (11): 50-55. 
doi: 10.1016/S1369-7021(04)00509-7
18. Kevadiya BD, Joshi GV, Bajaj HC. Layered bio-nanocomposites as carrier 
for procainamide. Int J Pharm. 2010; 388: 280-286. doi: 10.1016/j.
ijpharm.2010.01.002
19. Kianfar F, Antonijevic M, Chowdhry B, Boateng JS. Lyophilized wafers 
comprising κ-carrageenan &pluronic acid for buccal drug delivery using 
model soluble and insoluble drugs. Colloids Surf B. 2013; 101: 99-106. 
doi: 10.1016/j.colsurfb.2012.10.006
20. Matthews KH, Stevens HNE, Auffret AD, Humphrey MJ, Eccleston GM. 
Lyophilised wafers as a drug delivery system for wound healing containing 
methylcellulose as a viscosity modifier. International Journal of 
Pharmaceutics. 2005; 289 (1–2): 51–62. doi: 10.1016/j.ijpharm.2004.10.022
Madridge Journal of Novel Drug Research
9Volume 1 Issue 1Madridge J Nov Drug Res. 2017
21. Boateng JS, Matthews KH, Stevens HNE, Eccleston GM. Wound healing 
dressings and drug delivery systems: a review. J Pharm Sci. 2008; 97 (8): 
2892-2923. doi: 10.1002/jps.21210 
22. Kim GH, Kang YM, Kang KN, et al. Wound Dressings for Wound Healing 
and Drug Delivery. Tissue Eng Regen Med. 2011; 8 (1): 1-7. 
23. Murdande SB, Pikal MJ, Shanker RM, Bogner RH. Aqueous solubility of 
crystalline and amorphous drugs: Challenges in measurement. Pharm 
Dev Technol. 2011; 16(3): 187-200. doi: 10.3109/10837451003774377 
24. Babu JN, Nangia A. Solubility Advantage of Amorphous Drugs and 
Pharmaceutical Co-crystals. Cryst Growth Des. 2011; 11(7): 2662-2679. 
doi: 10.1021/cg200492w
25. Ebewele RO. Polymer science and technology. 2000. CRC Press LLC.
26. Siepmann J, Siepmann F. Mathematical modelling of drug delivery. Int J 
Pharm. 2008; 364: 328-343. doi: 10.1016/j.ijpharm.2008.09.004
27. Dash S, Murthy PM, Nath L, Chowdhury P. Kinetic modelling on drug 
release from controlled drug delivery systems. Acta Pol Pharm. 2010; 
67(3): 217-223.
28. Siepmann J, Siepmann F. Higuchi equation: derivation, applications, use and 
misuse. Int J Pharm. 2011; 418 (1): 6-12. doi: 10.1016/j.ijpharm.2011.03.051
29. Goyal A, Shukla P, Srivastava AK. Factors influencing drug release 
characteristic from hydrophilic polymer matrix tablet. Asian J Pharm Clin 
Res. 2009; 2 (1): 93-98. 
30. Carretero MI, Pozo M, Sánchez C, Garcia FJ, Medina JA, Bernabé JM. 
Comparison of saponite and montmorillonite behavior during static and 
stirring maturation with sea water for pelotherapy. Appl Clay Sci. 2007; 
36: 161-173. doi: 10.1016/j.clay.2006.05.010
31. Fu Y, Kao W. Drug Release Kinetics and Transport Mechanisms of 
Nondegradable. Expert Opin Drug Deliv. 2010; 7(4): 429-444. doi: 
10.1517/17425241003602259
32. Shiow-Fern Ng, Jumaat N. Carboxymethyl cellulose wafers containing 
antimicrobials: a modern drug delivery system for wound infections. 
European Journal of Pharmaceutical Sciences. 2014; 51: 173-179. doi: 
10.1016/j.ejps.2013.09.015
